almotriptan tablet
sanis health inc - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists
teva-almotriptan tablet
teva canada limited - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists
atorvastatin pharmathen 40 milligram film coated tablet
pharmathen s.a. - atorvastatin - film coated tablet - 40 milligram - hmg coa reductase inhibitors
atorvastatin pharmathen 20 milligram film coated tablet
pharmathen s.a. - atorvastatin calcium - film coated tablet - 20 milligram - hmg coa reductase inhibitors
atorvastatin pharmathen 80 milligram film coated tablet
pharmathen s.a. - atorvastatin calcium - film coated tablet - 80 milligram - hmg coa reductase inhibitors
atorvastatin pharmathen 10 milligram film coated tablet
pharmathen s.a. - atorvastatin calcium - film coated tablet - 10 milligram - hmg coa reductase inhibitors
bupropion hydrochloride (xl)- bupropion hydrochloride tablet, film coated, extended release
wockhardt usa llc. - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [ see clinical studies (14.1) ]. bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was estab
erycin 5.5% ww water soluble powder
nam pharma sdn. bhd. - erythromycin thiocynate -
erycin 300 gkg water soluble powder
nam pharma sdn. bhd. - erythromycin thiocynate -
probionexx probiotic support- bacillus coagulans, lactobacillus acidophilus and fiber capsule
skya health, llc - lactobacillus acidophilus (unii: 1prr1v42v5) (lactobacillus acidophilus - unii:1prr1v42v5), lacticaseibacillus casei (unii: sa940p2u00) (lacticaseibacillus casei - unii:sa940p2u00), lacticaseibacillus rhamnosus (unii: 9601ivb87j) (lacticaseibacillus rhamnosus - unii:9601ivb87j), bifidobacterium animalis lactis (unii: 5307v7xw8i) (bifidobacterium animalis lactis - unii:5307v7xw8i), lactiplantibacillus plantarum (unii: qfc21096on) (lactiplantibacillus plantarum - unii:qfc21096on), lactobacillus brevis (u -